BioCentury
ARTICLE | Clinical News

ASN100: Ph II started

February 10, 2017 9:21 PM UTC

Arsanis began a double-blind, placebo-controlled, international Phase II trial to evaluate a single dose of IV ASN100 in about 350 high-risk, mechanically ventilated patients. ASN100 was discovered un...